Anixa Biosciences (ANIX)
(Delayed Data from NSDQ)
$3.15 USD
-0.11 (-3.37%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $3.18 +0.03 (0.95%) 7:44 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
ANIXA BIOSCIENCES INC's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ANIX 3.15 -0.11(-3.37%)
Will ANIX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ANIX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ANIX
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?
ANIX: What are Zacks experts saying now?
Zacks Private Portfolio Services
ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy?
Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year?
What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now?
Other News for ANIX
ANIX: D. Boral Capital Reaffirms 'Buy' Rating with $10 Price Target | ANIX Stock News
Insider Buying: Titterton Lewis H jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX)
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine to Phase 2 Trials
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming ...
Anixa plans to begin Phase 2 of breast cancer vaccine trial